Walter M. Stadler

Also affiliated with University of Chicago

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment”.

Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment

medRxiv(2021)10.1101/2021.08.30.21262305

N/A

0.406DataRank · unranked

14 citations

Travis J. Meyers, Adaeze A. Emeka, Lauren Folgosa Cooley, Phillip R. Cooper, Nicola Lancki +92 more

Prevalence of potential interactions of medications, including herbs and supplements, before, during, and after chemotherapy in patients with breast and prostate cancer

Cancer(2021)10.1002/cncr.33324

N/A

0DataRank · unranked

38 citations

Nancy Kwon, Jimin Wu, Connie To, Steven To, Russell Z. Szmulewitz +6 more

Genetic factors associated with prostate cancer conversion from active surveillance to treatment

Human Genetics and Genomics Advances(2021)10.1016/j.xhgg.2021.100070

N/A

0DataRank · unranked

23 citations

Travis J. Meyers, Adaeze A. Emeka, Lauren Folgosa Cooley, Phillip R. Cooper, Nicola Lancki +92 more

Tissue based biomarkers in non-clear cell RCC: Correlative analysis from the ASPEN clinical trial

Kidney Cancer Journal(2021)10.52733/kcj19n3-a1

N/A

0DataRank · unranked

6 citations

Qian Yang, Andrea Carmack, Shiqi Zhang, Wen‐Chi Foo, Tim Eisen +15 more

A phase II study of sEphB4-HSA in metastatic castration-resistant prostate cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.084

N/A

0DataRank · unranked

1 citations

Masha Kocherginsky, Sabah Munir, Brenda Martone, Alicia K. Morgans, Walter M. Stadler +3 more

Accelerator-Based Production of Scandium Radioisotopes for Applications in Prostate Cancer: Toward Building a Pipeline for Rapid Development of Novel Theranostics

Molecules(2023)10.3390/molecules28166041

N/A

0DataRank · unranked

14 citations

Hannah J. Zhang, R. Freifelder, Mohammed Bhuiyan, Phillip Selman, Megan Mendez +19 more

Phase I trial of enzalutamide (Enz) plus the glucocorticoid receptor antagonist relacorilant (Rela) for patients with metastatic castration resistant prostate cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5062

N/A

0DataRank · unranked

6 citations

Anthony V. Serritella, Walter M. Stadler, Peter H. O’Donnell, Randy F. Sweis, Russell Z. Szmulewitz +1 more

Feasibility of structuring electronic health record data to facilitate real‐world data research: ICAREdata methods applied to multicenter cancer clinical trials

Cancer(2024)10.1002/cncr.35528

N/A

0DataRank · unranked

10 citations

Nancy Campbell, Shauna L. Hillman, Elizabeth S. Harlos, David Stein, Miranda Y. Chan +14 more

A phase II study of sEphB4-HSA in metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.tps274

N/A

0DataRank · unranked

1 citations

Vinay Sagar, Borko Jovanovic, Alicia K. Morgans, David James VanderWeele, David I. Quinn +4 more

Impact of postprogression therapies on overall survival: Recommendations from the 2023 kidney cancer association think tank meeting

Urologic Oncology Seminars and Original Investigations(2024)10.1016/j.urolonc.2024.10.022

N/A

0DataRank · unranked

5 citations

Salvatore La Rosa, Tian Zhang, Phillip M. Pierorazio, Laurence Albigès, Kathryn E. Beckermann +19 more